179 related articles for article (PubMed ID: 2764528)
1. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.
Gristina AG; Jennings RA; Naylor PT; Myrvik QN; Webb LX
Antimicrob Agents Chemother; 1989 Jun; 33(6):813-6. PubMed ID: 2764528
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci.
Naylor PT; Myrvik QN; Gristina A
Clin Orthop Relat Res; 1990 Dec; (261):126-33. PubMed ID: 2173986
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains.
Kotilainen P; Nikoskelainen J; Huovinen P
Scand J Infect Dis; 1991; 23(3):325-32. PubMed ID: 1882198
[TBL] [Abstract][Full Text] [Related]
4. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of four species of coagulase-negative staphylococci.
Fass RJ; Helsel VL; Barnishan J; Ayers LW
Antimicrob Agents Chemother; 1986 Oct; 30(4):545-52. PubMed ID: 3539009
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
7. Activity of LY146032 and vancomycin against coagulase-negative staphylococci.
Low DE; Poon R
Eur J Clin Microbiol; 1987 Apr; 6(2):190. PubMed ID: 3595581
[No Abstract] [Full Text] [Related]
8. Inhibition of Staphylococcus adherence to biomaterials by extracellular slime of S. epidermidis RP12.
Giridhar G; Kreger AS; Myrvik QN; Gristina AG
J Biomed Mater Res; 1994 Nov; 28(11):1289-94. PubMed ID: 7829558
[TBL] [Abstract][Full Text] [Related]
9. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
Marone P; Perversi L; Navarra A; Monzillo V; Sartirana E
J Chemother; 1993 Jun; 5(3):151-4. PubMed ID: 8396625
[TBL] [Abstract][Full Text] [Related]
10. Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility.
Sheth NK; Franson TR; Sohnle PG
Lancet; 1985 Dec; 2(8467):1266-8. PubMed ID: 2866335
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic studies of coagulase-negative staphylococci isolated from patients with nosocomial bacteraemias.
Ponce de Leon S; Guenthner SH; Wenzel RP
J Hosp Infect; 1986 Mar; 7(2):121-9. PubMed ID: 2871074
[TBL] [Abstract][Full Text] [Related]
12. Coagulase-negative staphylococci in air samples from operating theatres.
Kiss L; Sztroj T; Széll M
Acta Microbiol Immunol Hung; 1996; 43(1):39-46. PubMed ID: 8806942
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide.
Liebowitz LD; Saunders J; Chalkley LJ; Koornhof HJ
Antimicrob Agents Chemother; 1988 Jan; 32(1):24-6. PubMed ID: 2831813
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.
Venditti M; Santini C; Serra P; Micozzi A; Gentile G; Martino P
Antimicrob Agents Chemother; 1989 Feb; 33(2):209-11. PubMed ID: 2719465
[TBL] [Abstract][Full Text] [Related]
15. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.
Domaracki BE; Evans A; Preston KE; Fraimow H; Venezia RA
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):143-50. PubMed ID: 9665294
[TBL] [Abstract][Full Text] [Related]
16. A study of coagulase-negative staphylococci with reference to slime production, adherence, antibiotic resistance patterns and clinical significance.
Jones JW; Scott RJ; Morgan J; Pether JV
J Hosp Infect; 1992 Nov; 22(3):217-27. PubMed ID: 1362739
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of slime production and pathogenicity of coagulase-negative staphylococci].
Végh Z; Gacs M
Orv Hetil; 1990 Feb; 131(5):231-4. PubMed ID: 2406682
[TBL] [Abstract][Full Text] [Related]
18. Relationship between slime production, antibiotic sensitivity and the phagetype of coagulase-negative staphylococci.
Boussard P; Pithsy A; Devleeschouwer MJ
J Clin Pharm Ther; 1993 Aug; 18(4):271-4. PubMed ID: 8227235
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital.
Udo EE; Jacob LE; Chugh TD
Microb Drug Resist; 1995; 1(4):315-20. PubMed ID: 9158802
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
